Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A N Georgiadis

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinical and Experimental Rheumatology|July 9, 2003
Seropositive rheumatoid arthritis associated with Crohn's diseaseA N Georgiadis, N Tzambouras, E Ioachim, et al.
Scandinavian Journal of Rheumatology|May 19, 2010
Subclinical atherosclerosis in scleroderma patientsN Tsifetaki, A N Georgiadis, Y Alamanos, et al.
Scandinavian Journal of Rheumatology|October 3, 2008
Glucocorticoid receptor variants may predispose to rheumatoid arthritis susceptibilityA Chatzikyriakidou, I Georgiou, P V Voulgari, et al.
Annals of the Rheumatic Diseases|August 15, 2002
Infliximab treatment in combination with cyclosporin A in patients with severe refractory rheumatoid arthritisT I Temekonidis, A N Georgiadis, Y Alamanos, et al.
Scandinavian Journal of Rheumatology|May 28, 2004
Sinus histocytosis with massive lymphadenopathy (Rosai-Dorfman disease) in a patient with primary Sjogren's syndromeA A Drosos, A N Georgiadis, Z M Metafratzi, et al.
Rheumatology International|December 13, 2005
Psychological distress and personality traits in early rheumatoid arthritis: A preliminary surveyT N Hyphantis, M Bai, V Siafaka, et al.
Heart and Vessels|June 23, 2022
The effects of biologic agents on cardiovascular risk factors and atherosclerosis in rheumatoid arthritis patients: a prospective observational studyG V Papamichail, T E Markatseli, A N Georgiadis, et al.
Annals of the Rheumatic Diseases|December 4, 2003
Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month studyT I Temekonidis, Y Alamanos, S N Nikas, et al.
Annals of the Rheumatic Diseases|June 25, 2005
Efficacy and safety of switching from infliximab to adalimumab: a comparative controlled studyS N Nikas, P V Voulgari, Y Alamanos, et al.
Rheumatology International|December 14, 2005
Lymphocytic alveolitis: A surprising index of poor prognosis in patients with primary Sjogren's syndromeY A Dalavanga, P V Voulgari, A N Georgiadis, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical and Experimental Rheumatology|July 9, 2003
Seropositive rheumatoid arthritis associated with Crohn's diseaseA N Georgiadis, N Tzambouras, E Ioachim, et al.
Scandinavian Journal of Rheumatology|May 19, 2010
Subclinical atherosclerosis in scleroderma patientsN Tsifetaki, A N Georgiadis, Y Alamanos, et al.
Scandinavian Journal of Rheumatology|October 3, 2008
Glucocorticoid receptor variants may predispose to rheumatoid arthritis susceptibilityA Chatzikyriakidou, I Georgiou, P V Voulgari, et al.
Annals of the Rheumatic Diseases|August 15, 2002
Infliximab treatment in combination with cyclosporin A in patients with severe refractory rheumatoid arthritisT I Temekonidis, A N Georgiadis, Y Alamanos, et al.
Scandinavian Journal of Rheumatology|May 28, 2004
Sinus histocytosis with massive lymphadenopathy (Rosai-Dorfman disease) in a patient with primary Sjogren's syndromeA A Drosos, A N Georgiadis, Z M Metafratzi, et al.
Rheumatology International|December 13, 2005
Psychological distress and personality traits in early rheumatoid arthritis: A preliminary surveyT N Hyphantis, M Bai, V Siafaka, et al.
Heart and Vessels|June 23, 2022
The effects of biologic agents on cardiovascular risk factors and atherosclerosis in rheumatoid arthritis patients: a prospective observational studyG V Papamichail, T E Markatseli, A N Georgiadis, et al.
Annals of the Rheumatic Diseases|December 4, 2003
Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month studyT I Temekonidis, Y Alamanos, S N Nikas, et al.
Annals of the Rheumatic Diseases|June 25, 2005
Efficacy and safety of switching from infliximab to adalimumab: a comparative controlled studyS N Nikas, P V Voulgari, Y Alamanos, et al.
Rheumatology International|December 14, 2005
Lymphocytic alveolitis: A surprising index of poor prognosis in patients with primary Sjogren's syndromeY A Dalavanga, P V Voulgari, A N Georgiadis, et al.
Pageof 2